Hepatotoxicity in immune checkpoint inhibitors: a pharmacovigilance study from 2014-2021

HIGHLIGHTS

  • who: Ze Xu and colleagues from the Department of Pharmaceutical informatics, School of Shenyang Pharmaceutical University, Shenyang, Liaoning, China have published the article: Hepatotoxicity in immune checkpoint inhibitors: A pharmacovigilance study from 2014-2021, in the Journal: PLOS ONE of May/30,/2022
  • what: The aim of this study was to examine the relationship between ICIs and hepatotoxicity in a scientific and systematic manner. This study provides a reference for rational clinical use of drugs by data mining and analysis of safety signals of ICIs in the FAERS database, the adverse event reporting system of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?